Cargando…

Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease

BACKGROUND: Danqi pill (DQP) is one of the most widely prescribed formulas and has been shown to have remarkable protective effect on coronary heart disease (CHD). However, its regulatory effects on lipid metabolism disorders haven’t been comprehensively studied so far. We aimed to explore the effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Hong, Wang, Qiyan, Shi, Tianjiao, Huo, Kuiyuan, Li, Chun, Zhang, Qian, Wang, Guoli, Wang, Yuanyuan, Tang, Binghua, Wang, Wei, Wang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802898/ https://www.ncbi.nlm.nih.gov/pubmed/27000070 http://dx.doi.org/10.1186/s12906-016-1083-3

Ejemplares similares

DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
por: Wang, Yong, et al.
Publicado: (2014)

Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway
por: Wang, Yong, et al.
Publicado: (2015)

Multitarget Effects of Danqi Pill on Global Gene Expression Changes in Myocardial Ischemia
por: Wang, Qiyan, et al.
Publicado: (2018)

Pro-angiogenic Role of Danqi Pill Through Activating Fatty Acids Oxidation Pathway Against Coronary Artery Disease
por: Jiao, Shihong, et al.
Publicado: (2018)

Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway
por: Zhang, Qian, et al.
Publicado: (2020)

Effect and Mechanism of QiShenYiQi Pill on Experimental Autoimmune Myocarditis Rats
por: Lv, Shichao, et al.
Publicado: (2016)

QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats
por: Lv, Shichao, et al.
Publicado: (2021)

The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1α pathway
por: Wang, Qiyan, et al.
Publicado: (2016)

Effect of QiShenYiQi Pill on Myocardial Collagen Metabolism in Rats with Partial Abdominal Aortic Coarctation
por: Lv, Shichao, et al.
Publicado: (2015)

QiShenYiQi pill improves the reparative myocardial fibrosis by regulating autophagy
por: Lv, Shichao, et al.
Publicado: (2020)

Cardioprotective Effects of QiShenYiQi Dripping Pills on Transverse Aortic Constriction-Induced Heart Failure in Mice
por: Ruan, Guoran, et al.
Publicado: (2018)

Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial
por: Shang, Hongcai, et al.
Publicado: (2013)

Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill(®) via ameliorate of multiple mitochondrial dysfunctions
por: Chen, Jing Rui, et al.
Publicado: (2015)

QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
por: Lv, Shichao, et al.
Publicado: (2022)

An Analysis of the Anti-Neuropathic Effects of Qi She Pill Based on Network Pharmacology
por: Song, Yong-jia, et al.
Publicado: (2020)

QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats
por: Ding, Congyang, et al.
Publicado: (2022)

Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
por: Zhang, Jun, et al.
Publicado: (2022)

Qi Dan Li Xin pill improves chronic heart failure by regulating mTOR/p70S6k-mediated autophagy and inhibiting apoptosis
por: Shi, Binhao, et al.
Publicado: (2020)

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
por: Zhang, Jun, et al.
Publicado: (2022)

QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in Rats
por: Tang, Dong-Xin, et al.
Publicado: (2013)

Study on the mechanism of Jin Gui Shen Qi Pill in the treatment of erectile dysfunction based on bioinformatics analysis
por: Xiang, Jingjing, et al.
Publicado: (2022)

QiShenYiQi Pills, a Compound Chinese Medicine, Prevented Cisplatin Induced Acute Kidney Injury via Regulating Mitochondrial Function
por: Zhou, Li, et al.
Publicado: (2017)

QiShenYiQi pill attenuates atherosclerosis by promoting regulatory T cells, inhibiting T helper 17 cells and accelerating cholesterol excretion
por: Peng, Li, et al.
Publicado: (2017)

The Contribution of Different Components in QiShenYiQi Pills® to Its Potential to Modulate Energy Metabolism in Protection of Ischemic Myocardial Injury
por: Cui, Yuan-Chen, et al.
Publicado: (2018)

Uncovering the mechanisms of Yi Qi Tong Qiao Pill in the treatment of allergic rhinitis based on Network target analysis
por: Wang, Boyang, et al.
Publicado: (2023)

Luteolin Prevents H(2)O(2)-Induced Apoptosis in H9C2 Cells through Modulating Akt-P53/Mdm2 Signaling Pathway
por: Chang, Hong, et al.
Publicado: (2016)

QiShenYiQi pill activates autophagy to attenuate reactive myocardial fibrosis via the PI3K/AKT/mTOR pathway
por: Lv, Shichao, et al.
Publicado: (2021)

QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode
por: Chen, Yuan-Yuan, et al.
Publicado: (2015)

The Effect of Chinese Medicine on Lipid and Glucose Metabolism in Acute Myocardial Infarction Through PPARγ Pathway
por: Zhang, Qian, et al.
Publicado: (2018)

Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism
por: Li, Chun, et al.
Publicado: (2016)

Qi-Shen-Yi-Qi Dripping Pills Promote Angiogenesis of Ischemic Cardiac Microvascular Endothelial Cells by Regulating MicroRNA-223-3p Expression
por: Dai, Guo-Hua, et al.
Publicado: (2016)

Simultaneous determination of nineteen major components in Qi She Pill by ultra-high-performance liquid chromatography–tandem mass spectrometry
por: Zhang, Zhongliang, et al.
Publicado: (2014)

QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway
por: Anwaier, Gulinigaer, et al.
Publicado: (2022)

Combination Therapy of PPARγ Ligands and Inhibitors of Arachidonic Acid in Lung Cancer
por: Tauler, Jordi, et al.
Publicado: (2008)

Cell Survival Signalling through PPARδ and Arachidonic Acid Metabolites in Neuroblastoma
por: Bell, Emma, et al.
Publicado: (2013)

QiShenYiQi Pills Attenuates Ischemia/Reperfusion-Induced Cardiac Microvascular Hyperpermeability Implicating Src/Caveolin-1 and RhoA/ROCK/MLC Signaling
por: Pan, Chun-Shui, et al.
Publicado: (2021)

Circulating MicroRNA Profiles Differ between Qi-Stagnation and Qi-Deficiency in Coronary Heart Disease Patients with Blood Stasis Syndrome
por: Hou, Jincai, et al.
Publicado: (2014)

Danqi soft capsule prevents infarct border zone remodelling and reduces susceptibility to ventricular arrhythmias in post‐myocardial infarction rats
por: Ma, Shiyu, et al.
Publicado: (2019)

Effect of Danqi Buxin Decoction on Chronic Function Indexes and Life Quality in Patients with Chronic Heart Failure of Yang Deficiency Type
por: Sheng, Yunjiao, et al.
Publicado: (2021)

To compare the efficacy of two kinds of Zhizhu pills in the treatment of functional dyspepsia of spleen-deficiency and qi-stagnation syndrome:a randomized group sequential comparative trial
por: Wu, Hongli, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hafvj7pnj14rlbvtud6ot070ug